Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Share-based Compensation (2018 - 2026)

Alector's (ALEC) quarterly Share-based Compensation came in at $2.6 million in Q2 2026, down 63.04% year-over-year from $7.1 million in Q2 2025, and down 10.25% quarter-over-quarter from $2.9 million in Q1 2026.

Analysis

Alector (ALEC) Share-based Compensation (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Share-based Compensation for 9 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Share-based Compensation fell 63.04% year-over-year to $2.6 million in Q2 2026; TTM through Jun 2026 was $16.8 million, a 51.64% decrease from a year earlier, with the FY2025 full-year figure at $26.7 million, down 36.83% from the prior year.
  • Share-based Compensation was $2.6 million for Q2 2026 at Alector, down from $2.9 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $13.7 million in Q2 2022 and troughed at $2.6 million in Q2 2026.
  • A 5-year average of $9.4 million and a median of $10.1 million in 2023 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation increased 18.09% in 2022 and tumbled 65.18% in 2026, its largest moves.
  • Over 5 years, Share-based Compensation stood at $11.0 million in 2022, then increased by 5.28% to $11.5 million in 2023, then fell by 11.52% to $10.2 million in 2024, then slumped by 52.58% to $4.8 million in 2025, then tumbled by 46.11% to $2.6 million in 2026.
  • The last three Share-based Compensation figures came in at $2.6 million (Q2 2026), $2.9 million (Q1 2026), and $4.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 86.63 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 77.40 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 41.25 Mn
10 Alector 274.68 Mn 101.88 Mn - 2.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.61 Mn
Mar 31, 2026 2.91 Mn
Dec 31, 2025 4.84 Mn
Sep 30, 2025 6.40 Mn
Jun 30, 2025 7.06 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 10.21 Mn
Sep 30, 2024 9.04 Mn
Jun 30, 2024 9.91 Mn
Mar 31, 2024 10.31 Mn
Dec 31, 2023 11.54 Mn
Sep 30, 2023 10.06 Mn
Jun 30, 2023 12.26 Mn
Mar 31, 2023 12.66 Mn
Dec 31, 2022 10.96 Mn
Sep 30, 2022 13.19 Mn
Jun 30, 2022 13.74 Mn
Mar 31, 2022 12.52 Mn
Dec 31, 2021 12.71 Mn
Sep 30, 2021 11.17 Mn